Thirty years later, an AAV vector was used to deliver the cystic fibrosis transmembrane regulator (CFTR) gene packaged with the AAV2 capsid (rAAV2-CFTR), into a patient with cystic fibrosis [47]. This evidence concerns the gene CFTR and cystic fibrosis.